SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is under intense scrutiny as it celebrates its 50th anniversary, facing a dual narrative of potential long-term growth through its push into budget-friendly hardware and immediate volatility driven by reported engineering delays on its foldable iPhone and patent infringement setbacks in China. Investors are closely monitoring how the company balances its massive cash reserves against potential settlement costs, while the community remains divided between those bullish on its core ecosystem stability and others wary of its lagging position in the aggressive AI integration race.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing significant price volatility as investors react to the CMS finalization of a 2027 Medicare Advantage rate hike, which came in stronger than previously feared projections. While some market participants are celebrating this as a major relief rally and a catalyst for a short squeeze, others remain cautious due to ongoing sector-wide regulatory uncertainty and concerns over broader market pressures.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending following the formalization of a long-term, multi-year AI chip partnership with Google that extends through 2031, alongside an expanded compute capacity agreement with Anthropic. Investors are actively discussing the stock's role as foundational infrastructure for hyperscale AI deployments, with the market monitoring whether this strategic catalyst can shift sentiment after a period of price consolidation.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is facing significant downward pressure as investors weigh premium valuation concerns and potential macro sensitivity against its role as a key data provider for AI model training. The community is sharply divided, with bulls pointing to the company's long-term data licensing potential and share buyback program, while bears highlight heavy insider selling, concerns over bot-inflated user metrics, and the platform's broader content moderation controversies.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is trending following a significant leadership overhaul that replaced CEO Peter Greenleaf with Chairman Kevin Tang, a move that the community widely interprets as a clear signal that the company is being positioned for a potential buyout. Investors are closely monitoring how Tangs new management team will leverage existing assets, such as Lupkynis and the Aritinercept pipeline, to maximize shareholder value.

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Humana Inc.

Humana Inc

Humana and other managed care stocks are surging following a finalized Medicare Advantage payment rate from CMS that exceeded initial market fears and projections. Investors are actively discussing the revenue stability this decision provides for the sector, while others remain focused on navigating volatility and assessing the long-term impacts of policy shifts on insurer margins.

Space and Time is the data blockchain securing onchain finance. Backed by Microsoft’s Venture Fund M12, Space and Time connects real-world data to onchain systems to power tokenized assets, stablecoins, institutional markets, and DeFi.  The SXT token is deployed as an ERC-20 token on Ethereum and functions as the network's native utility token. SXT is used for staking, data processing payments, access control, and incentives for data contributors.

Space and Time

Space and Time (SXT) is gaining significant community traction due to its high-profile technological partnerships, including integrations with Microsoft and Samsung, as well as its focus on verifiable, AI-ready data infrastructure. While some investors are bullish on the project's long-term potential and institutional backing, others are debating the impact of recent token unlocks and questioning its short-term price volatility.

Generac Holdings, Inc. engages in the business of designing and manufacturing energy technology solutions. It operates under the Domestic and International segments. The Domestic segment includes the legacy Generac business and the acquisitions that are based in the United States and Canada. The International segment focuses on Generac business' Latin American export operations. The company was founded in 1959 and is headquartered in Waukesha, WI.

Generac Holdings Inc

Generac is trending due to the intersection of elevated demand for backup power following recent severe hurricane activity and a newly proposed presidential policy to make home generator purchases tax-deductible. The community is actively debating the stock's role as a resilient 'picks and shovels' play in the face of aging grid infrastructure, with some investors eyeing the current volatility as a tactical entry point.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is gaining attention as community members rally behind what they claim is the authentic, original version of the long-standing meme, contrasting it with previous fraudulent copies. Investors are actively discussing its historical roots, its perceived potential as a counter-culture asset, and its ability to maintain relevance in the meme coin landscape.

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals is in the spotlight as investors await upcoming Phase 2 pediatric trial data for zelicapavir, which the company expects to provide insights into its RSV treatment strategy. Community sentiment remains focused on the potential of Enanta's RSV portfolio and immunology pipeline to address significant unmet market needs despite recent volatility and broader competitive pressures in the biotech sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SiBone $SIBN Stake Lowered by JPMorgan Chase & Co.

JPMorgan Chase & Co. decreased its stake in SiBone (NASDAQ:SIBN - Free Report) by 32.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange...

SiBone (NASDAQ:SIBN) Given Average Recommendation of "Moderate Buy" by Analysts

Shares of SiBone (NASDAQ:SIBN - Get Free Report) have been given a consensus rating of "Moderate Buy" by the seven ratings firms that are currently covering the firm, Marketbeat.com reports. One...

Insider Selling: SiBone (NASDAQ:SIBN) SVP Sells 1,335 Shares of Stock

SiBone (NASDAQ:SIBN - Get Free Report) SVP Michael Pisetsky sold 1,335 shares of the company's stock in a transaction dated Thursday, April 2nd. The shares were sold at an average price of $12.86, for a total transaction of $17,168.10. Following the transaction, the senior vice president owned...

SiBone (NASDAQ:SIBN) SVP Sells $17,168.10 in Stock

SiBone (NASDAQ:SIBN - Get Free Report) SVP Michael Pisetsky sold 1,335 shares of SiBone stock in a transaction that occurred on Thursday, April 2nd. The shares were sold at an average price of $12.86, for a total value of $17,168.10. Following the sale, the senior vice president directly owned...

SiBone (NASDAQ:SIBN) SVP Michael Pisetsky Sells 1,799 Shares

SiBone (NASDAQ:SIBN - Get Free Report) SVP Michael Pisetsky sold 1,799 shares of the company's stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $12.95, for a total value of $23,297.05. Following the transaction, the senior vice president...

SiBone (NASDAQ:SIBN) CFO Sells $42,702.66 in Stock

SiBone (NASDAQ:SIBN - Get Free Report) CFO Anshul Maheshwari sold 3,318 shares of SiBone stock in a transaction dated Thursday, April 2nd. The shares were sold at an average price of $12.87, for a total value of $42,702.66. Following the sale, the chief financial officer owned 263,148 shares of the...

SiBone (NASDAQ:SIBN) Sees Large Growth in Short Interest

SiBone (NASDAQ:SIBN - Get Free Report) was the target of a large increase in short interest during the month of March. As of March 13th, there was short interest totaling 3,603,947 shares, an increase of 25.5% from the February 26th total of 2,871,776 shares. Approximately 8.5% of the company's...

SiBone (NASDAQ:SIBN) Upgraded by Wall Street Zen to Buy Rating

Wall Street Zen raised SiBone from a "hold" rating to a "buy" rating in a research report on Saturday...

SiBone (NASDAQ:SIBN) Sets New 12-Month Low - What's Next?

SiBone (NASDAQ:SIBN) Reaches New 52-Week Low - Here's What Happened...

Granahan Investment Management LLC Sells 224,678 Shares of SiBone $SIBN

Granahan Investment Management LLC lessened its position in shares of SiBone (NASDAQ:SIBN - Free Report) by 17.8% during the 3rd quarter, according to its most recent Form 13F filing with the...

SI-BONE, Inc. is a medical device company, which engages in the provision of a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of musculoskeletal disorders of the sacropelvic anatomy. It offers a proprietary minimally invasive surgical implant system, called iFuse, used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in Santa Clara, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.19	--	--	N/A
Q4 '25	-$0.13	-$0.04	68.25%	BEAT
Q3 '25	-$0.17	-$0.11	33.91%	BEAT
Q2 '25	-$0.18	-$0.14	23.64%	BEAT
Q1 '25	-$0.23	-$0.15	33.54%	BEAT

SIBN
SI-BONE Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest SIBN News

SIBNSI-BONE Inc